Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2022-09-30 00:00:00 ET · period of report 2022-09-28 · accession 0001209191-22-051650 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-09-30 | 2022-09-28+ | KTTA | Camac Fund, LP | Member of 10% owner group | P - Purchase | $1.19 | +64.4K | 1.79M | +4% | +$76.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-28 | P | A | 57,647 | $1.19 | 1,781,705 | I See footnote | — | — | (F1) The shares are held by Camac Fund, LP. ("Camac Fund"). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC. |
| 2 | Common | Common Stock | 2022-09-29 | P | A | 6,710 | $1.16 | 1,788,415 | I See footnote | — | — | (F1) The shares are held by Camac Fund, LP. ("Camac Fund"). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC. |